Cargando…
Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease
This article describes the chemical synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel Nurr1/NOT agonist. It is meant as a support to an article recently published in Bioorganic and Medicinal chemistry Letters and entitled “Development of a n...
Autores principales: | Malanda, André, Abécassis, Pierre-Yves, Barnéoud, Pascal, Brunel, Pascale, Taupin, Véronique, Vigé, Xavier, Lesuisse, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820105/ https://www.ncbi.nlm.nih.gov/pubmed/31687426 http://dx.doi.org/10.1016/j.dib.2019.104057 |
Ejemplares similares
-
Pharmacological investigations of new galantamine peptide esters
por: Tsvetkova, Dobrina, et al.
Publicado: (2014) -
Synthesis and Pharmacological Evaluation of Novel Schiff Base Analogues of 3-(4-amino) Phenylimino) 5-fluoroindolin-2-one
por: Nirmal, R, et al.
Publicado: (2010) -
A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
por: Smith, Gaynor A., et al.
Publicado: (2015) -
Network pharmacology‐based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil
por: Yang, Zhirui, et al.
Publicado: (2022) -
Data set describing the in vitro biological activity of JMV2009, a novel silylated neurotensin(8–13) analog
por: Besserer-Offroy, Élie, et al.
Publicado: (2020)